FIELD: medicine; phthisiology.
SUBSTANCE: invention use for treatment of infiltrative and disseminated pulmonary tuberculosis. Perform chemotherapy providing introduction of preparations of Isoniazidum, Rifampicin, Pyrazinamidum, and also Ethambutolum or Streptomycin. In addition prescribe Populin vegetative preparation.
EFFECT: rising of efficiency of treatment and reduction of by-effects of chemotherapy.
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR REDUCING ADVERSE SIDE EFFECTS IN TREATING FOR TUBERCULOSIS | 2006 |
|
RU2314113C2 |
| PULMONARY TUBERCULOSIS TREATMENT METHOD | 2002 |
|
RU2195313C1 |
| METHOD FOR DETERMINING THE GENETIC PREDISPOSITION TO THE DEVELOPMENT OF MULTIDRUG-RESISTANT TUBERCULOSIS MYCOBACTERIUM TUBERCULOSIS IN HIV INFECTION | 2020 |
|
RU2750715C1 |
| ANTITUBECULOUS-CAUSED MEDICAMENTOUS POLYNEUROPATHY APPROACH | 2007 |
|
RU2353360C2 |
| METHOD FOR TREATMENT OF ADVERSE NEUROTOXIC RESPONSE CAUSED BY ANTITUBERCULOSIS PREPARATIONS | 2006 |
|
RU2312667C1 |
| METHOD FOR CHOOSING THERAPEUTIC APPROACH FOR PATIENTS WITH NEWLY DIAGNOSED INFILTRATIVE PULMONARY TUBERCULOSIS | 2015 |
|
RU2602683C1 |
| METHOD FOR TREATING PULMONARY TUBERCULOSIS | 2004 |
|
RU2253460C1 |
| METHOD FOR TREATING HUMAN TUBERCULOSIS | 2002 |
|
RU2238091C2 |
| ANTITUBERCULOSIS AGENT | 2002 |
|
RU2210379C1 |
| ANTITUBERCULOUS REMEDY | 2002 |
|
RU2672904C1 |
